| 1. |
Zhu X, Chen WB, Xing FB, et al. Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor-a retrospective study of 8 cases. Front Oncol, 2022, 12: 840886.
|
| 2. |
Nishadham V, Rao S, Saravanan A, et al. Inflammatory myofibroblastic tumors: A short series with an emphasis on the diagnostic and therapeutic challenges. Clin Neuropathol, 2023, 42(3): 100-111.
|
| 3. |
Zhang J, Li Y, Lou L. Uterine metastases originating from a pulmonary inflammatory myofibroblastic tumor. J Cancer Res Ther, 2018, 14(Supplement): S257-S259.
|
| 4. |
Ramos JG, Ochoa A, Cicutti S, et al. Inflammatory myofibroblastic tumor of the lung involving the central nervous system in pediatric patients. Childs Nerv Syst, 2023, 39(5): 1137-1145.
|
| 5. |
趙珂, 張家齊, 饒可, 等. 肺部炎性肌纖維母細胞瘤的診療: 單中心回顧性研究并文獻綜述. 中華胸心血管外科雜志, 2022, 38(6): 380-384.
|
| 6. |
Zuo T, Fu J, Ni Z, et al. Pulmonary inflammatory Myofibroblastic tumor indistinguishable from tuberculosis: a case report in a five-year-old child with hemoptysis. J Cardiothorac Surg, 2017, 12(1): 112.
|
| 7. |
丁茹, 盛少潔, 貢其星. 炎性肌纖維母細胞瘤的分子遺傳學研究進展. 中華病理學雜志, 2021, 50(12): 1415-1418.
|
| 8. |
Zhang N, Zeng Q, Chen C, et al. Clinical characteristics and prognosis of pulmonary inflammatory myofibroblastic tumor: An over 10-year retrospective analysis. Pediatr Investig, 2020, 4(3): 192-197.
|
| 9. |
Ponzoni M, Reffo E, Basso C, et al. Recurrent pulmonary embolization of inflammatory myofibroblastic tumor: a case report. Cardiovasc Pathol, 2021, 50: 107270.
|
| 10. |
Demir ?F, Onal O. Surgical treatment outcomes of pulmonary inflammatory myofibroblastic tumors. Ann Thorac Med, 2022, 17(1): 44-50.
|
| 11. |
龍源, 潘頻華, 李園園, 等. 肺巨大炎性肌纖維母細胞瘤一例并文獻復習. 中國呼吸與危重監護雜志, 2019, 18(3): 254-258.
|
| 12. |
Siemion K, Reszec-Gielazyn J, Kisluk J, et al. What do we know about inflammatory myofibroblastic tumors? - A systematic review. Adv Med Sci, 2022, 67(1): 129-138.
|
| 13. |
Wu J, Zhu H, Li K, et al. Imaging observations of pulmonary inflammatory myofibroblastic tumors in patients over 40 years old. Oncol Lett, 2015, 9(4): 1877-1884.
|
| 14. |
Héluain V, Hermant C, Borel C, et al. Bronchoscopic Treatment of Endobronchial Inflammatory Myofibroblastic Tumors. Ann Thorac Surg, 2021, 111(2): e109-e111.
|
| 15. |
韓曉紅, 俞同福. 肺炎性肌纖維母細胞瘤的CT診斷價值. 醫學影像學雜, 2018, 28(1): 51-53,56.
|
| 16. |
Ma C, Lu J, Chen G, et al. Inflammatory myofibroblastic tumor mimicking lymphoma on 18F-FDG PET/CT. Report of a case and review of the literature. Hell J Nucl Med, 2018, 21(1): 77-80.
|
| 17. |
Eldaabossi S, Maghmoul L, Lotfy E, et al. Common Presentation of Uncommon Disease: Inflammatory myofibroblastic tumor of the lung, case report. Respir Med Case Rep, 2022, 37: 101656.
|
| 18. |
Nakano K. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy. Jpn J Clin Oncol, 2023, 53(10): 885-892.
|
| 19. |
Gleason B C, Hornick J L, Inflammatory myofibroblastic tumours: where are we now?J Clin Pathol, 2008, 61(4): 428-37.
|
| 20. |
Liu X, Gong C, Zhang J, et al. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study. Cancer Res Treat, 2023, 55(3): 1001-1010.
|
| 21. |
廖雪蓮, 蔣莎義, 楊靜薇, 等. 克唑替尼治療兒童 ALK基因突變陽性炎性肌纖維母細胞瘤4例. 中華實用兒科臨床雜志, 2022, 37(11): 861-863.
|
